5th RSC / DMDG / DMG New perspectives in DMPK

22 February 2022 11:30 - 23 February 2022 15:30, Liverpool, United Kingdom

Further information
Please visit the event website, https://www.rscbmcs.org/events/dmpk.

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.
The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK
In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

Programme Themes
Session 1 - DMPK and Drug Discovery
Understanding chemical and biological interactions that mediate pharmacological and toxicological effects of drugs and their metabolites is an important part of the drug discovery picture. In this session, we will showcase some of the more recent developments in our collective understanding of

Session 2 - DMPK and Drug Safety
This session will provide an interdisciplinary platform for academics and scientists to present and discuss the most recent innovations and practical challenges in the fields of DMPK to address drug safety, and particularly the emerging safety issues relating to biotherapeutics. It will include presentations on transporters associated with drug-induced tissue injury, new in vitro models for mechanistic toxicity assessment, and recent developments in predicting intrinsic immunogenicity of drugs.

Session 3 - Analytical and Computational Advances in DMPK
Advances in analytical and computational performance, and the availability of new instruments, methods, and approaches commonly unlocks new knowledge about compound stability, reactivity, interaction, and disposition. This session will showcase recent developments in bioanalytical science and computational modelling that have provided fresh insight and understanding in DMPK.

Who should attend
Medicinal chemists, drug discovery scientists, pharmacologists, toxicologists, DMPK scientists – from academia, industry, and third sector institutions 
Liverpool Medical Institution

LMI Conference Centre, Liverpool Medical Institution, 114 Mount Pleasant, Liverpool, L3 5SR, United Kingdom

  • Toby Athersuch Imperial College London and the DMG, United Kingdom
  • Dean Naisbitt University of Liverpool, United Kingdom
  • Xiaoli Meng University of Liverpool, United Kingdom
  • Andrew Stachulski University of Liverpool and RSC-BMCS, United Kingdom
  • Mark Seymour PharMAS Consulting and DMDG, United Kingdom

Organised by
RSC BMCS (Biological and Medicinal Chemistry Sector)
DMDG (Drug Metabolism Discussion Group)
DMG (The Drug Metabolism Group)
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry